Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins

European Journal of Immunology

Volumn 32, Issue 12, 2002, Pages 3414-3424

  Krause, Ilan ^a   Blank, Miri ^a   Sherer, Yaniv ^a   Gilburd, Boris ^a   Kvapil, Filip ^a   Shoenfeld, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti idiotype; Antiphospholipid syndrome; CD8 cell; Intravenous immunoglobulin; Oral tolerance

Indexed keywords

CD8 ANTIGEN; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERLEUKIN 10; OMRIGAM; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN STRUCTURE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GLYCOPROTEINS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; IMMUNOTHERAPY; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 85047697357     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200212)32:12<3414::AID-IMMU3414>3.0.CO;2-F     Document Type: Article

References (52)

1. Weiner, H. L., Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 1997. 18: 335-343.
2. Weiner, H. L., Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 2000. 106: 935-937.
3. Strober, W., Kelsall, B. and Marth, T., Oral tolerance. J. Clin. Immunol. 1998.18: 1-30.
4. Krause, I., Blank, M. and Shoenfeld, Y., Immunomodulation of experimental autoimmune diseases via oral tolerance. Crit. Rev. Immunol. 2000. 20: 1-16.
5. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L., Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995. 376: 177-180.
6. Whitacre, C. C., Gienapp, I. E., Orosz, C. G. and Bitar, D. M., Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 1991. 147: 2155-2163.
7. Van Houten, N. and Blake, S. F., Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J. Immunol. 1996. 157: 1337-1341.
8. Friedman, A. and Weiner, H. L., Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994. 91: 6688-6692.
9. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994. 265: 1237-1240.
10. Khoury, S. J., Hancock, W. W. and Weiner, H. L., Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 1992. 176: 1355-1364.
11. Gregerson, D. S., Obritsch, W. F. and Donoso, L. A., Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J. Immunol. 1993. 151: 5751-5761.
12. Benson, J. M., Campbell, K. A., Guan, Z., Gienapp, I. E., Stuckman, S. S., Forsthuber, T. and Whitacre, C. C., T cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 2000. 106: 1031-1038.
13. Wardrop, R. M. and Whitacre, C. C., Oral tolerance in the treatment of inflammatory autoimmune diseases. Inflamm. Res. 1999. 48: 106-119.
14. Blank, M., George, J., Barak, V., Tincani, A., Koike, T. and Shoenfeld, Y., Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. J. Immunol. 1998.161: 5303-5312.
15. Dietrich, G. and Kazatchkine, M. D., Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J. Clin. Invest. 1990. 85: 620-625.
16. Dietrich, G., Algiman, M., Sultan, Y., Nydegger, U. E. and Kazatchkine, M. D., Origin of anti-idiotypic activity against antifactor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood 1992. 79: 2946-2951.
17. Rossi, F. and Kazatchkine, M. D., Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J. Immunol. 1989. 143: 4104-4109.
18. Rossi, F., Jayne, D. R., Lockwood, C. M. and Kazatchkine, M. D., Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin. Exp. Immunol. 1991. 83: 298-303.
19. Silvestris, F., Cafforio, P. and Dammacco, F., Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations. Clin. Exp. Immunol. 1994. 97: 19-25.
20. Berchtold, P., Dale, G. L., Tani, P. and McMillan, R., Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by antiidiotypic antibodies in intravenous gammaglobulin. Blood 1989. 74: 2414-2417.
21. Krause, I., Blank, M. and Shoenfeld, Y., Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice. J. Clin. Immunol. 1998. 18: 52-60.
22. Jerne, N. K., Roland, J. and Cazenave, P. A., Recurrent idiotopes and internal images. EMBO J. 1982. 1: 243-247.
23. Caccavo, D., Vaccaro, F., Ferri, G. M., Amoroso, A. and Bonomo, L., Anti-idiotypes against anti phospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use. J. Autoimmun. 1994. 7: 537-548.
24. Krause, I., Blank, M., Kopolovic, J., Afek, A., Goldberg, I., Tomer, Y. and Shoenfeld, Y., Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. J. Rheumatol. 1995. 22: 1068-1074.
25. Shoenfeld, Y., Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J. 1994. 8: 1296-1301.
26. Peng, H. J., Turner, M. W. and Strobel, S., The kinetics of oral hyposensitization to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration. Immunology 1989. 67: 425-430.
27. Conde, A. A., Stransky, B., Faria, A. M. and Vaz, N. M., Interruption of recently induced immune responses by oral administration of antigen. Braz. J. Med. Biol. Res. 1998. 31: 377-380.
28. Torseth, J. W. and Gregerson, D. S., Oral tolerance in experimental autoimmune uveoretinitis: feeding after disease induction is less protective than prefeeding. Clin. Immunol. Immunopathol. 1998. 88: 297-304.
29. Leishman, A. J., Garside, P. and Mowat, A. M., Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form. Cell Immunol. 2000. 202: 71-78.
30. Leishman, A. J., Garside, P. and Mowat, A. M., Immunological consequences of intervention in established immune responses by feeding protein antigens. Cell Immunol. 1998. 183: 137-148.
31. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. and Weiner, H. L., Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 1992. 89: 421-425.
32. Teitelbaum, D., Arnon, R. and Sela, M., Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc. Natl. Acad. Sci. USA 1999. 96: 3842-3847.
33. Thompson, H. S., Harper, N., Bevan, D. J. and Staines, N. A., Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity 1993. 16: 189-199.
34. Rizzo, L. V., Morawetz, R. A., Miller-Rivero, N. E., Choi, R., Wiggert, B., Chan, C. C., Morse, H. C., 3rd, Nussenblatt, R. B. and Caspi, R. R., IL-4 and IL-10 are both required for the induction of oral tolerance. J. Immunol. 1999. 162: 2613-2622.
35. Hancock, W. W., Polanski, M., Zhang, J., Blogg, N. and Weiner, H. L., Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am. J. Pathol. 1995. 147: 1193-1199.
36. Ma, C. G., Zhang, G. X., Xiao, B. G., Wang, Z. Y., Link, J., Olsson, T. and Link, H., Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. Ann. N Y Acad. Sci. 1996. 778: 273-287.
37. Prud'homme, G. J. and Piccirillo, C. A., The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J. Autoimmun. 2000. 14: 23-42.
38. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 1994. 24: 793-798.
39. Bright, J. J., Kerr, L. D. and Sriram, S., TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J. Immunol. 1997. 159: 175-183.
40. + intraepithelial lymphocytes. Nature 1988. 333: 855-858.
41. Bonneville, M., Janeway, C. A., Jr, Ito, K., Haser, W., Ishida, I., Nakanishi, N. and Tonegawa, S., Intestinal intraepithelial lymphocytes are a distinct set of T cells. Nature 1988. 336: 479-48.
42. Mengel, J., Cardillo, F., Aroeira, L. S., Williams, O., Russo, M. and Vaz, N. M., Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 1995. 48: 97-102.
43. Ke, Y., Pearce, K., Lake, J. P., Ziegler, H. K. and Kapp, J. A., Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 1997. 158: 3610-3618.
44. Fujihashi, K., Dohi, T., Kweon, M. N., McGhee, J. R., Koga, T., Cooper, M. D., Tonegawa, S. and Kiyono, H., Gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int. Immunol. 1999. 11:1907-1916.
45. Mombaerts, P., Arnoldi, J., Russ, F., Tonegawa, S. and Kaufmann, S. H. E., Different roles of αβ and γδ cells in immunity against an intracellular bacterial pathogen. Nature 1993. 365: 53-56.
46. Tsuji, M., Mombaerts, P., Lefranciois, L., Nussenzweig, R. S., Zavala, F. and Tonegawa, S., γδT cells contribute to immunity against the liver stages of malaria in ß T cell-deficient mice. Proc. Natl. Acad. Sci. USA 1994. 91: 345-349.
47. Ladel, C. H., Hess, J., Daugelat, S., Mombaerts, P., Tonegawa, S. and Kaufmann, S. H. E., Contribution of αβ and γδ lymphocytes to immunity against Mycobacterium bovis Bacillus Calmette Guerin: studies with T cell receptor-deficient mutant mice. Eur. J. Immunol. 1995. 25: 2877-2881.
48. Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A. and Shoenfeld, Y., Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J. Clin. Invest. 2002. 109: 797-804.
49. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
50. Alpan, O., Rudomen, G. and Matzinger, P., The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J. Immunol. 2001. 166: 4843-4852.
51. Akbari, O., DeKruyff, R. H. and Umetsu, D. T., Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001. 2: 725-731.
52. Weiner, H. L., The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat. Immunol. 2001. 2: 671-672.